Charles & Colvard Reports Equity Sales, Officer Changes
| Field | Detail |
|---|---|
| Company | Charles & Colvard Ltd |
| Form Type | 8-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: equity-sale, corporate-governance, filing
Related Tickers: CTAS
TL;DR
C&C filed an 8-K detailing unregistered equity sales and board/officer changes.
AI Summary
Charles & Colvard, Ltd. filed an 8-K on August 26, 2025, reporting on events that occurred on August 21, 2025. The filing indicates unregistered sales of equity securities and updates regarding director and officer appointments and compensatory arrangements. It also includes financial statements and exhibits.
Why It Matters
This filing provides crucial updates on the company's equity transactions and corporate governance, which can impact investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — Unregistered equity sales can sometimes signal dilution or insider activity, while changes in officers and directors warrant attention for potential strategic shifts.
Key Players & Entities
- Charles & Colvard, Ltd. (company) — Registrant
- August 21, 2025 (date) — Earliest event reported
- August 26, 2025 (date) — Date of report
FAQ
What type of equity securities were sold unregistered?
The filing indicates unregistered sales of equity securities but does not specify the exact type in the provided text.
What specific compensatory arrangements are detailed?
The filing mentions compensatory arrangements of certain officers but does not provide specific details in the excerpt.
Who were the directors or officers involved in the reported changes?
The filing notes departure of directors or certain officers and election/appointment of others, but specific names are not in the provided text.
What financial statements and exhibits are included?
The filing states that financial statements and exhibits are included, but their specific content is not detailed in the excerpt.
What is the significance of the filing date being later than the event date?
The filing date of August 26, 2025, is when the report was submitted to the SEC, while the earliest event reported occurred on August 21, 2025, as required by SEC regulations.
Filing Stats: 899 words · 4 min read · ~3 pages · Grade level 11.8 · Accepted 2025-08-25 21:44:24
Filing Documents
- tm2524338d1_8k.htm (8-K) — 30KB
- tm2524338d1_ex10-1.htm (EX-10.1) — 16KB
- 0001104659-25-082695.txt ( ) — 207KB
- cthr-20250821.xsd (EX-101.SCH) — 3KB
- cthr-20250821_lab.xml (EX-101.LAB) — 33KB
- cthr-20250821_pre.xml (EX-101.PRE) — 22KB
- tm2524338d1_8k_htm.xml (XML) — 3KB
02 Unregistered Sales of Equity Securities
Item 3.02 Unregistered Sales of Equity Securities. On August 21, 2025, Charles & Colvard Ltd. (the "Company") issued unregistered restricted stock units as described below under Item 5.02, in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 21, 2025, in order to incentivize director, employee and key consultant performance and align their interests with the shareholders at this critical time in the Company's history, the Compensation Committee of the Board of Directors (the "Board") of Charles & Colvard, Ltd. approved the Charles & Colvard, Ltd. (the "Company") Fiscal 2026 Executive Incentive Program (the "FY2026 Program"), with effect as of July 1, 2025. The total number of Restricted Stock Units ("RSUs") to be authorized under the FY2026 Program is 1,338,000. The FY2026 Program supersedes and replaces all prior management incentive plans or programs for all periods commencing on or after July 1, 2025. Each award granted under the FY2026 Program shall be expressed in "Units" and each Unit shall consist of, at grantee's election: Option A – (1) a restricted stock award representing 65% of the Unit (the "Restricted Stock Component"), granted to the grantee, and (2) a cash bonus award representing 35% of the Unit (the "Cash Component"), to be paid to the grantee (for employees on the payroll date following the vesting date, and for consultants and non-employee Board members within one month of the vesting date); or Option B – a restricted stock award representing 100% of the Unit granted to the grantee. Grantees must elect Option A or Option B within one (1) week after the Company files its Form 10-K for FY2025, and grantees are only allowed to change their election for future tranches no less than three (3) months before such electio
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Document 10.1 Charles & Colvard, Ltd. Fiscal 2026 Executive Incentive Program, effective July 1, 2025 + 104 Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL Document + Denotes management contract or compensatory plan or arrangement SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Charles & Colvard, Ltd. August 25, 2025 By: /s/ Clint J. Pete Clint J. Pete Chief Financial Officer